Sign In
Buy IUGNF
$0.0750
+0 (+0%)
At Close: Jul 13, 2026
Figma shares rise as Bank of America resumes coverage with a ‘Buy’ rating
12:02pm, Tuesday, 07'th Jul 2026
Figma (NYSE:FIG) was reinstated with a ‘Buy’ rating and a $30 price objective by Bank of America, with the firm arguing that artificial intelligence is...
Imugene raises $11.1 million to advance azer-cel after complete responses in early cohort
07:36am, Tuesday, 07'th Jul 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) is raising about A$11.12 million before costs through a two-tranche placement, strengthening its balance sheet as...
Shell flags 'significantly higher' gas trading and sells South Africa business - UPDATE
04:38am, Tuesday, 07'th Jul 2026
Shell PLC (LSE:SHEL, NYSE:SHEL) shares jumped over 2% after it said stronger trading and improved refining margins should support second-quarter...
Imugene reports second BTKi cohort response - ICYMI
06:00am, Saturday, 04'th Jul 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF) earlier this week reported a second complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or BTKi, cohort...
Imugene CEO details azer-cel trial milestone - ICYMI
06:41am, Friday, 03'rd Jul 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor, or...
Anthropic clears export hurdle for Fable 5, easing a threat to its IPO story
07:10am, Wednesday, 01'st Jul 2026
The most striking thing about the standoff that ended on Tuesday is not that it ended, but that it happened at all: a US government blocking a US company...
Imugene reports second complete response in azer-cel BTKi cohort
06:59am, Wednesday, 01'st Jul 2026
Just a day after reporting the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its ongoing Phase 1b azer-cel...
Fed may adopt leaner communications strategy under Warsh, says Deutsche Bank
06:00am, Wednesday, 01'st Jul 2026
Federal Reserve communications are likely to become shorter, less reliant on forward guidance and more focused on longer-term economic narratives under new...
Nasdaq leads Wall Street higher, Dow Jones notches new record as second quarter ends
12:15pm, Tuesday, 30'th Jun 2026
4:15pm: Best quarter since 2020 Wall Street has wrapped up its best quarter since 2020, with the Dow Jones adding another 0.3% on Friday to close at a fresh...
Imugene reports first complete response in azer-cel BTKi cohort
08:27am, Tuesday, 30'th Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported the first complete response in the concurrent Bruton Tyrosine Kinase inhibitor (BTKi) cohort of its...
FDA Fast Track opens new path for Imugene's Azer-cel - ICYMI
06:38am, Friday, 12'th Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week announced that the US Food and Drug Administration (FDA) granted Fast Track Designation to its...
Inside Biotech: FDA fast-track nod sharpens focus on Imugene's off-the-shelf CAR T ambitions
10:32am, Tuesday, 09'th Jun 2026
CAR T therapies have transformed treatment options for some blood cancers. They have also exposed one of cell therapy's biggest practical limitations: time....
Thor Energy lifted by hydrogen project update
06:14am, Tuesday, 09'th Jun 2026
Thor Energy PLC (AIM:THR, OTCQB:THORF, ASX:THR) shares lifted 25%, to 0.75p, after it said Phase-2 survey work at its HY-Range project in South Australia...
Imugene showcases Azer-Cel progress at ASCO - ICYMI
07:07am, Friday, 05'th Jun 2026
Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at...
Dow Jones, Nasdaq close at record levels as Trump says US-Iran peace talks are advancing
12:15pm, Monday, 01'st Jun 2026
4:15pm: Peace optimism boosts stocks US stocks finished Monday’s session higher on renewed hopes a peace deal would be struck between the US and Iran, with...
